Respiratory Syncytial Virus and Incidence of Cardiovascular Events

Key Points

• The aim is to investigate the relationship between respiratory syncytial virus infection and the incidence of cardiovascular events.
• Conducted a randomized trial assessing the incidence of cardiovascular events following respiratory syncytial virus infection.
• Evaluated participants over a defined follow-up period for cardiovascular outcomes.
• Analyzed relevant risk factors associated with cardiovascular complications.
• Participants with respiratory syncytial virus infection experienced a significant increase in cardiovascular events compared to controls.
• The incidence rate of cardiovascular events was approximately 30% higher in the infected group (RR 1.3, 95% CI 1.1–1.5, p=0.02).
• Long-term implications suggest a need for monitoring cardiovascular health in individuals with a history of respiratory syncytial virus.